The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials
BACKGROUND: Several cluster-randomized HIV prevention trials aim to demonstrate the population-level preventive impact of antiretroviral therapy (ART). 2013 World Health Organization (WHO) guidelines raising the ART initiation threshold to CD4 <500/µL could attenuate these trials' effect siz...
Main Authors: | Ross, E. (Author), Tanser, F. (Author), Pei, P. (Author), Newell, M.L (Author), Losina, E. (Author), Thiebaut, R. (Author), Weinstein, M. (Author), Freedberg, K. (Author), Anglaret, X. (Author), Scott, C. (Author), Dabis, F. (Author), Walensky, R. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2014-09.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa.
by: Jan A C Hontelez, et al.
Published: (2011-01-01) -
Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004-2012: a prospective cohort study
by: Vandormael, A., et al.
Published: (2014) -
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
by: Andrea L Ciaranello, et al.
Published: (2011-01-01) -
HIV cure strategies: how good must they be to improve on current antiretroviral therapy?
by: Paul E Sax, et al.
Published: (2014-01-01) -
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
by: Jeffrey K Hom, et al.
Published: (2012-01-01)